Related Experiment Video
Updated: Jul 10, 2026
Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
Published on: February 2, 2024
Small molecule-regulated switches to provide functional control of CAR T cells within the patient
Charlotte U Zajc1,2, Elise Sylvander2,3, Manfred Lehner2,3,4
1Department of Chemistry, Institute of Biochemistry, BOKU University, Vienna, Austria.
Introduction:
CAR T cells have generated great excitement due to their remarkable clinical response rates in selected hematologic malignancies. However, these engineered immune cells are living drugs which are hard to control after administration.
Areas Covered:
We discuss small molecule-regulated switch systems which can potentially be used to control CAR T cell function within the patient, as well as the most important obstacles in the CAR T cell field, which might be overcome with those switch systems.
Expert Opinion:
There is an urgent need to develop advanced switch systems. Once available, we expect that they will open up new avenues for future CAR T cell generations.
Insights
Chimeric antigen receptor (CAR) T-cell therapy shows promise but lacks control. Small molecule-regulated switch systems offer a potential solution for managing these living drugs and advancing future CAR T-cell therapies.
Area of Science:
- Immunotherapy
- Cellular Therapy
- Biotechnology
Background:
- Chimeric antigen receptor (CAR) T-cell therapy has demonstrated significant efficacy in treating certain blood cancers.
- CAR T cells are engineered living drugs that present challenges in controlling their activity post-administration.
Purpose of the Study:
- To explore small molecule-regulated switch systems for controlling CAR T-cell function.
- To identify key obstacles in CAR T-cell therapy that could be addressed by these switch systems.
Main Methods:
- Discussion of small molecule-regulated switch systems.
- Analysis of current challenges in CAR T-cell therapy.
Main Results:
- Small molecule switches offer a potential mechanism for regulating CAR T-cell activity in vivo.
- These systems may help overcome critical limitations in the clinical application of CAR T cells.
Conclusions:
- There is a critical need for advanced switch systems to enhance CAR T-cell therapy.
- Development of these systems is expected to pave the way for next-generation CAR T-cell therapies.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Tumor Immunotherapy